Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,580 | 350 | 4,960 | 3,280 | 1,920 |
| Depreciation Amortization | 970 | 350 | 1,600 | 1,300 | 930 |
| Other Working Capital | -3,630 | -390 | 0 | -3,060 | 290 |
| Other Operating Activity | 0 | 0 | -1,490 | 0 | 20 |
| Operating Cash Flow | $-1,080 | $310 | $5,070 | $1,520 | $3,160 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -630 | -130 | -810 | -760 | -1,030 |
| Net Acquisitions | 0 | 0 | -3,150 | 0 | 0 |
| Other Investing Activity | -3,630 | -3,640 | -10 | 40 | 10 |
| Investing Cash Flow | $-4,260 | $-3,770 | $-3,970 | $-720 | $-1,020 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,870 | 3,180 | 2,160 | 970 | -430 |
| Financing Cash Flow | $2,870 | $3,180 | $2,160 | $970 | $-430 |
| Exchange Rate Effect | 340 | -100 | -290 | -230 | -180 |
| Beginning Cash Position | 5,050 | 5,050 | 2,080 | 2,080 | 2,080 |
| End Cash Position | 2,920 | 4,670 | 5,050 | 3,620 | 3,600 |
| Net Cash Flow | $-2,130 | $-380 | $2,970 | $1,530 | $1,520 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,080 | 310 | 5,070 | 1,520 | 3,160 |
| Free Cash Flow | -1,080 | 310 | 5,070 | 1,520 | 3,160 |